HPCP gets a fair amount of comments on our social media platforms about why are there more ads for HIV testing in Pennsylvania. We’ve also been hearing a lot about unscientific, unfounded connections between COVID vaccines and HIV. The *real* connection to the need for more testing and COVID is that people stopped getting tested for HIV during the COVID crisis. Now HPCP is helping to make up for lost ground. As reported by Contagion Live, the pandemic disrupted testing among vulnerable populations (see below). As a result, HPCP, in partnership with Penn State University, is offering free HIV self-test kits to anyone who resides in Pennsylvania, you can find out more and get a FREE HIV self-test kit in the mail at www.getmyHIVtest.com.
The COVID-19 pandemic significantly disrupted HIV testing and new diagnoses among vulnerable populations, according to a Morbidity and Mortality Weekly Report from the US Centers for Disease Control and Prevention (CDC).
CDC investigators analyzed data from national data collection systems in order to compare the numbers of HIV tests performed and HIV infections diagnosed in the US. in the years prior to (2019) and during (2020) the COVID-19 pandemic. The study authors noted that due to the pandemic, health care systems were disrupted including HIV testing and the redirection of some public health departments from sexual health services towards COVID-19 services.
Individuals with HIV who began taking antiretroviral therapy (ART) in the early stages of infection achieved a lengthy period of HIV suppression without ART after receiving two broadly neutralizing anti-HIV antibodies (bNAbs), according to a small study published today in the journal Nature . The findings suggest that combination bNAb therapy might offer a future alternative to daily ART for people living with HIV. […]
The purpose of the study was to see if treatment with the bNAbs could suppress HIV in the absence of ART. None of the seven participants who received the bNAb treatment had to restart ART before 28 weeks post-infusion compared to six of the seven participants who received placebo.
Saturday, April 10, marks National Youth HIV & AIDS Awareness Day (NYHAAD) 2021. Traditionally, it’s a “day to educate the public about the impact of HIV and AIDS on young people,” according to the nonprofit Advocates for Youth, which spearheads NYHAAD.
The group adds, “The day also highlights the HIV prevention, treatment and care campaigns of young people in the U.S.”
This year, the HIV awareness day also includes a call to action. Youth advocates want you to help them convince Congress to pass the REPEAL HIV Discrimination Act. “REPEAL” stands for: “Repeal Existing Policies that Encourage and Allow Legal” HIV Discrimination.
The REPEAL HIV Discrimination Act aims to modernize HIV crime laws, such as those that set harsh sentences for people with HIV who allegedly don’t disclose their status before sex—even if they’re undetectable and HIV was not transmitted. (To read a collection of POZ articles about such laws and efforts to change them, click #Criminalization.)
You can support Advocates for Youth’s call to action by filling out an online form that will generate a letter to send to members of Congress.
A woman with HIV who received a cord blood stem cell transplant to treat acute myeloid leukemia has had no detectable levels of HIV for 14 months despite cessation of antiretroviral therapy (ART), according to a presentation at today’s Conference on Retroviruses and Opportunistic Infections (CROI).
This is the third known case of HIV remission in an individual who received a stem cell transplant. The research was conducted by the International Maternal Pediatric Adolescent AIDS Clinical Trial Network (IMPAACT) P1107 observational study led by Yvonne Bryson, M.D., of the University of California Los Angeles, and Deborah Persaud, M.D., of Johns Hopkins University, Baltimore. The IMPAACT network is funded by the National Institutes of Health.
The IMPAACT P1107 study began in 2015 and was a U.S.-based observational study designed to describe the outcomes of up to 25 participants living with HIV who underwent a transplant with CCR5Δ32/Δ32 cord blood stem cells for treatment of cancer, hematopoietic disease, or other underlying disease. As a result of the genetic mutation CCR5Δ32/Δ32, missing cells lack CCR5 co-receptors, which is what HIV uses to infect cells. By killing off the cancerous immune cells via chemotherapy and then transplanting stem cells with the CCR5 genetic mutation, scientists theorize that people with HIV then develop an HIV-resistant immune system.
Monday, February 7, marks National Black HIV/AIDS Awareness Day (NBHAAD) 2022. By numerous measures, Black Americans are disproportionately affected by the HIV epidemic. NBHAAD highlights related challenges while raising awareness about prevention, testing, treatment and more.
“This #NBHAAD we are focused on equity,” tweeted the Centers for Disease Control and Prevention’s Division of HIV Prevention, adding: “We must end unequal access to #HIV prevention & care, & address root causes that contribute to disparities in HIV such as poverty, stigma, systemic racism, & unequal access to healthcare & education.”
In 2020, African Americans represented 12% of the U.S. population age 13 and older but accounted for 43% of new HIV diagnoses, according to AIDSVu.org, which analyzes HIV data and creates related infographics and interactive maps.
Disproportionate HIV rates are more pronounced in the South, where in 2020, Black Americans accounted for 52% of new HIV diagnoses but made up only 19% of the population in that region.
Greetings on this World AIDS Day, and my solidarity with all around the world as we confront the impact of colliding pandemics.
This year, the world agreed on a bold plan that, if leaders fulfil it, will end AIDS by 2030. That’s so exciting.
But today we, as the Joint United Nations Programme on HIV/AIDS, issue a stark warning. AIDS remains a pandemic, the red light is flashing and only by moving fast to end the inequalities that drive the pandemic can we overcome it.
Where leaders are acting boldly and together, bringing together cutting-edge science, delivering services that meet all people’s needs, protecting human rights and sustaining adequate financing, AIDS-related deaths and new HIV infections are becoming rare.
But this is only the case in some places and for some people.
Without the inequality-fighting approach we need to end AIDS, the world would also struggle to end the COVID-19 pandemic and would remain unprepared for the pandemics of the future. That would be profoundly dangerous for us all.
Progress in AIDS, which was already off track, is now under even greater strain as the COVID-19 crisis continues to rage, disrupting HIV prevention and treatment services, schooling, violence prevention programmes and more.
On our current trajectory, we aren’t bending the curve fast enough and risk an AIDS pandemic lasting decades. We have to move faster on a set of concrete actions agreed by United Nations Member States to address the inequalities that are driving HIV.
Through fighting the AIDS pandemic, we have learned a lot about what we need more of for AIDS and for all pandemics.
We urgently need sufficient community-led and community-based infrastructure as part of a strong public health system, underpinned by robust civil society accountability.
We need policies to ensure fair and affordable access to science.
Every new technology should reach each and everyone who needs it without delay.
We need to protect our health workers and expand their numbers to meet our urgent needs.
We must protect human rights and build trust in health systems.
It is these that will ensure we close the inequality gaps and end AIDS. But they are too often applied unevenly, are underfunded and are underappreciated.
I salute the front-line communities that have pioneered the approaches shown to be most effective, that have driven the momentum for change and that are pushing leaders to be bold. I urge you: keep pushing.
World leaders must work together urgently to tackle these challenges head-on. I urge you: be courageous in matching words with deeds.
There is not a choice to be made between ending the AIDS pandemic that is raging today and preparing for the pandemics of tomorrow. The only successful approach will achieve both. As of now, we are not on track to achieve either.
If we take on the inequalities that hold back progress, we can deliver on the promise to end AIDS by 2030. It is in our hands.
Every minute that passes, we are losing a precious life to AIDS. We don’t have time.
In one patient, viral suppression lasted nearly three and a half years, with occasional rebounds in virus counts. The other patient had nearly complete HIV suppression for close to four years, but then had a big surge when he was infected with a different HIV strain, a situation called “superinfection.”
In the first patient, researchers found high levels of HIV-specific immune cells called CD8+ T cells that can kill virus-infected cells.
The second patient had a weaker CD8+ T cell response against HIV, but a very strong neutralizing antibody response until the sudden viral rebound.
Are you a resident of Pennsylvania who has been impacted by HIV/AIDS? Consider volunteering for the HIV Planning Group (HPG)! The HPG contributes to the development of the HIV Prevention and Care Plan for the State Department of Health. The Plan implements ongoing activities to reduce HIV and improve the quality of life of people living with HIV.
Tell Me About It: HIV Conversations in the Community is a six-part podcast series of honest conversations, sharing accurate and trustworthy information about HIV and sexual and reproductive health in a friendly and open way.
It’s a personal, engaging and honest look at what it really means to live with HIV today, and how that’s changed significantly over the years. Each episode shares developments in prevention and treatment that allow people living with HIV to live long and healthy lives free of fear, and shatters some of the most damaging myths about HIV and its impact on sex, life expectancy, starting a family, staying well, mental health and public attitudes.
It was inspired by the conversations that people living with HIV often find themselves having with those unaware of how HIV has changed in recent years: How did you get it? Aren’t you just a drain on NHS resources? Can I catch it off you? Will you die young?
Hosted by writer, researcher, international performance poet and TEDx speaker Bakita Kasadha, each episode is a conversation between people sharing their experiences of HIV. Most pair a person who is living with HIV and another person who does not have the virus.
Most scientific studies relating to HIV and transgender people focus on transgender women — research about HIV and transgender men is limited.
According to research from 2018, this is because HIV prevalence is thought to be higher among transgender women: approximately 25–31%, compared with 0–3% among transgender men.
Other research, from the University of California San Francisco, suggests that trans MSM have an increased risk of contracting HIV, including those who do sex work.
This research states that in one study, most trans MSM reported not consistently using a condom during receptive anal and frontal sex with non-trans male partners. Participants also reported low rates of HIV testing and a low perception of the risk.